Doxapram-induced panic attacks and cortisol elevation

Psychiatry Research

Volumn 133, Issue 2-3, 2005, Pages 253-261

  Gutman, David A ^a   Coplan, Jeremy ^b   Papp, Laszlo ^c   Martinez, Jose ^d   Gorman, Jack ^d  

^a School of Medicine ^*  (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Cortisol; Doxapram; Panic attacks; Ventilatory stimulant

Indexed keywords

DOXAPRAM; HYDROCORTISONE; PROLACTIN;

ADULT; AGORAPHOBIA; ANXIETY; ARTICLE; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; MALE; NORADRENERGIC SYSTEM; PANIC; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; RATING SCALE;

EID: 14644432395     PISSN: 01651781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psychres.2004.10.010     Document Type: Article

References (37)

1. J.L. Abelson, G.C. Curtis, R. Nesse, R. Fantone, R.E. Pyke, and J. Bammert-Adams The effects of central cholecystokinin receptor blockade on hypothalamic-pituitary-adrenal and symptomatic responses to overnight withdrawal from alprazolam Biological Psychiatry 37 1995 56 59
2. J.L. Abelson, R.M. Nesse, J.G. Weg, and G.C. Curtis Respiratory psychophysiology and anxiety: cognitive intervention in the doxapram model of panic Psychosomatic Medicine 58 1996 302 313
3. J.L. Abelson, J.G. Weg, R.M. Nesse, and G.C. Curtis Neuroendocrine responses to laboratory panic: cognitive intervention in the doxapram model Psychoneuroendocrinology 21 1996 375 390
4. American Psychiatric Association The Diagnostic and Statistical Manual of Mental Disorders (DSM-III R) 1987 Author Washington, DC
5. D.W. Austin, and J.C. Richards The catastrophic misinterpretation model of panic disorder Behaviour Research and Therapy 39 2001 1277 1291
6. G.A. Borg Psychophysical bases of perceived exertion Medicine and Science in Sports and Exercise 14 1982 377 381
7. J. Bradwejn, and D. Koszycki The cholecystokinin hypothesis of anxiety and panic disorder Annals of the New York Academy of Sciences 713 1994 273 282
8. J. Bradwejn, and D. Koszycki Cholecystokinin and panic disorder: past and future clinical research strategies Scandinavian Journal of Clinical & Laboratory Investigation Supplement 234 2001 19 27
9. N.K. Burki Ventilatory effects of doxapram in conscious human subjects Chest 85 1984 600 604
10. P.M. Calverley, R.H. Robson, P.K. Wraith, L.F. Prescott, and D.C. Flenley The ventilatory effects of doxapram in normal man Clinical Science 65 1983 65 69
11. D.S. Charney, G.R. Heninger, and A. Breier Noradrenergic function in panic anxiety. Effects of yohimbine in healthy subjects and patients with agoraphobia and panic disorder Archives of General Psychiatry 41 1984 751 763
12. J. Coplan, and D. Klein Pharmacological probes in panic disorder H. Westenberg J. Boer D. Murphy Advances in the Neurobiology of Anxiety Disorders 1996 Wiley Chichester 173 196
13. J.D. Coplan, D. Pine, L. Papp, J. Martinez, T. Cooper, L.A. Rosenblum, and J.M. Gorman Uncoupling of the noradrenergic-hypothalamic-pituitary-adrenal axis in panic disorder patients Neuropsychopharmacology 13 1995 65 73
14. J.D. Coplan, L.A. Papp, D. Pine, J. Martinez, T. Cooper, L.A. Rosenblum, D.F. Klein, and J.M. Gorman Clinical improvement with fluoxetine therapy and noradrenergic function in patients with panic disorder Archives of General Psychiatry 54 1997 643 648
15. J.D. Coplan, R.C. Trost, M.J. Owens, T.B. Cooper, J.M. Gorman, C.B. Nemeroff, and L.A. Rosenblum Cerebrospinal fluid concentrations of somatostatin and biogenic amines in grown primates reared by mothers exposed to manipulated foraging conditions Archives of General Psychiatry 55 1998 473 477
16. J.D. Coplan, R. Goetz, D.F. Klein, L.A. Papp, A.J. Fyer, M.R. Liebowitz, S.O. Davies, and J.M. Gorman Plasma cortisol concentrations preceding lactate-induced panic. Psychological, biochemical, and physiological correlates Archives of General Psychiatry 55 1998 130 136
17. M. Davis The role of the amygdala in fear and anxiety Annual Review of Neuroscience 15 1992 353 375
18. D.J. Dillon, J.M. Gorman, M.R. Liebowitz, A.J. Fyer, and D.F. Klein Measurement of lactate-induced panic and anxiety Psychiatry Research 20 1987 97 105
19. H. Folgering, A. Vis, and J. Ponte Ventilatory and circulatory effects of doxapram, mediated by carotid body chemoreceptors Bulletin Europeen de Physiopathologie Respiratoire 17 1981 237 241
20. J.M. Gorman, M.R. Fyer, R. Goetz, J. Askanazi, M.R. Liebowitz, A.J. Fyer, J. Kinney, and D.F. Klein Ventilatory physiology of patients with panic disorder Archives of General Psychiatry 45 1988 31 39
21. J.M. Gorman, J.M. Kent, G.M. Sullivan, and J.D. Coplan Neuroanatomical hypothesis of panic disorder, revised American Journal of Psychiatry 157 2000 493 505
22. C.F. Jensen, E.R. Peskind, R.C. Veith, J. Hughes, D.S. Cowley, P. Roy-Byrne, and M.A. Raskind Hypertonic saline infusion induces panic in patients with panic disorder Biological Psychiatry 30 1991 628 630
23. Kent, J.M., Coplan J.D., Mawlawi O., Martinez J.M., Browne S.T., Slifstein M., Martinez D., Abi-Dargham A., Laruelle M., Gorman J.M., in press. Reduced orbitofrontal CBF predicts panic response to a respiratory stimulant in panic disorder. American Journal of Psychiatry.
24. E. Klein, J. Zohar, M.F. Geraci, D.L. Murphy, and T.W. Uhde Anxiogenic effects of m-CPP in patients with panic disorder: comparison to caffeine's anxiogenic effects Biological Psychiatry 30 1991 973 984
25. D. Koszycki, R.M. Zacharko, J.M. Le Melledo, and J. Bradwejn Behavioral, cardiovascular, and neuroendocrine profiles following CCK-4 challenge in healthy volunteers: a comparison of panickers and nonpanickers Depression and Anxiety 8 1998 1 7
26. J. LeDoux The Emotional Brain: The Mysterious Underpinnings of Emotional Life 1996 Simon and Schuster New York
27. J.E. LeDoux, J. Iwata, P. Cicchetti, and D.J. Reis Different projections of the central amygdaloid nucleus mediate autonomic and behavioral correlates of conditioned fear Journal of Neuroscience 8 1988 2517 2529
28. Y.J. Lee, G.C. Curtis, J.G. Weg, J.L. Abelson, J.G. Modell, and K.M. Campbell Panic attacks induced by doxapram Biological Psychiatry 33 1993 295 297
29. M.R. Liebowitz, J.M. Gorman, A.J. Fyer, M. Levitt, D. Dillon, G. Levy, I.L. Appleby, S. Anderson, M. Palij, S.O. Davies, and D.F. Klein Lactate provocation of panic attacks: II. Biochemical and physiological findings Archives of General Psychiatry 42 1985 709 719
30. S.J. Mathew, J.D. Coplan, K.A. Perko, R.R. Goetz, M. de la Neuz, E. Hollander, M.R. Liebowitz, and B.A. Fallon Neuroendocrine predictors of response to intravenous clomipramine therapy for refractory obsessive-compulsive disorder Depression and Anxiety 14 2001 199 208
31. L.A. Papp, D.F. Klein, J. Martinez, F. Schneier, R. Cole, M.R. Liebowitz, E. Hollander, A.J. Fyer, F. Jordan, and J.M. Gorman Diagnostic and substance specificity of carbon-dioxide-induced panic American Journal of Psychiatry 150 1993 250 257
32. R.E. Pyke, and H.S. Greenberg Norepinephrine challenges in panic patients Journal of Clinical Psychopharmacology 6 1986 279 285
33. R. Spitzer, J. Williams, M. Gibbon, and M. First Structured Clinical Interview for the DSM III-R 1990 American Psychiatric Association
34. G.M. Sullivan, J. Apergis, J.M. Gorman, and J.E. LeDoux Rodent doxapram model of panic: behavioral effects and c-fos immunoreactivity in the amygdala Biological Psychiatry 53 2003 863 870
35. S.D. Targum, and L.E. Marshall Fenfluramine provocation of anxiety in patients with panic disorder Psychiatry Research 28 1989 295 306
36. D.J. Veltman, G.A. van Zijderveld, and R. van Dyck Epinephrine infusions in panic disorder: a double-blind placebo-controlled study Journal of Affective Disorders 39 1996 133 140
37. A.P. Winnie Chemical respirogenesis: a comparative study Acta Anaesthesiologica Scandinavica. Supplement 51 1973 1 32